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Lesson learned/recommendation: In Nepal, 15% of HIV
positive individuals being co-infected with Hepatitis B is
a recent threat to the health authority since both the
infections share a similar route of transmission which may
contribute to the devastating AIDS epidemic. Hepatitis B
screening should be made mandatory for all HIV sero-
positive individuals.
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Background: The dysfunction of T cells may represent
a mechanism of hepatitis B virus (HBV) persistence.
Programmed death-1 (PD-1) and its ligands, PD-L1/PD-L2,
are new members of CD28/B7 family, was reported to
transfer inhibitory signal, leading to the dysfunction of
T cells.
Methods and Patients: Immunohistochemical analysis of
tissue samples from 56 patients with chronic hepatitis B
(CHB), 12 acute hepatitis B (AHB) patients and 10 health
controls was performed.
Results: PD-1 was positively expressed in inﬂammatory cells
inﬁltrating the portal area dominantly. PD-L1 expression
was more extensive, apart from the in portal area,
also expressed on hepatocytes and sinusoidal endothelial
cells. PD-L2 mostly expressed on kupffer cells (KCs) and
dendritic cells (DCs) in portal area as well as interlobular.
The PD-1-, PD-L1-positive cells on lymphocytes inﬁltrating
portal area of CHB patients was 32.33%± 30.56% and
30.68%± 27.07% respectively, more than that of health
controls (2.68%± 2.37%, 5.3%± 5.62% p < 0.05) and that of
AHB patients (12%± 9.6%, 8.7%± 7.4% p < 0.05). The PD-
L2-positive cells on KCs and DCs in CHB patients was
much higher (6.57%± 7.21%) than that in AHB patients
(15.7%± 8.2%) and health controls (2.06%± 2.35%), p < 0.05.
According to the the severity of illness index, the PD-1,
PD-L1, and PD-L2 expression rate within CHB patients
was increase with the disease progression (p < 0.05). The
expression of PD-L1 in interlobular in CHB was assayed
also, in severity group the number of higher score was
more than that in mild groups. And the expression of PD-1
on lymphocytes was correlated positively both with ALT
(r = 0.484, p < 0.05) and AST (r = 0.721, p < 0.05), although
had not apparent correlation with plasma DNA.
Conclusion: Overexpression of PD-1 and PD-L within liver
might be involved in inhibiting the immune response and be
a mechanism of chronicity in HBV infection.
PP-020 Hepatic steatosis is associated with host
metabolic factors but not viral effect in Chinese
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Aims: To investigate the prevalence and the risk factors
of hepatic steatosis in Chinese patients with chronic
hepatitis B.
Methods: Patients infected with hepatitis B virus who
underwent liver biopsy were included. One hundred and
sixty-one patients with chronic hepatitis B were divided
into two groups depending on the presence or absence
of steatosis in liver biopsy specimens. The relationships
of steatosis and demographic, laboratory and histological
characteristics were evaluated. Liver necroinﬂammatory
activity and ﬁbrosis were evaluated according to the
Knodell and Ishak’s classiﬁcation, respectively. Detection
of HBsAg and HBcAg were performed in liver specimen
by immunohistochemistry. Logistic regression analysis was
applied to identify variables that were independently
associated with the presence of steatosis.
Results: Hepatic steatosis was present in 53 patients
with chronic hepatitis B (53/161, 32.9%). Steatosis was
predominantly macrovesicular (49/53, 92.4%). Steatosis
was associated with ages (P < 0.001), BMI (P < 0.001),
fasting blood sugar (P = 0.001), cholesterol (P = 0.011) and
triglyceride (P = 0.004). In the multivariate analysis both
BMI (P= 0.036) and cholesterol (P = 0.021) were independent
predictors of the presence of steatosis. No signiﬁcant
correlation was found with gender, ALT, AST, TBil, ALP,
GGT, HBeAg, hepatitis B viral load, and histological ﬁndings
between the two groups (P > 0.05). HBsAg and HBcAg were
also detected in hepatocytes contain fat vacuoles.
Conclusion: Hepatic steatosis is present in 32.9% of
patients with biopsy-proven chronic hepatitis B. Steatosis
is independently associated with ages, BMI, fasting blood
sugar, cholesterol and triglyceride, suggesting being as a
result of metabolic factors of the host rather than the
effect of viruses and it seems to have not impact the
necroinﬂammatory activity and ﬁbrosis.
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Background: The dysfunction of T cells may represent
a mechanism of hepatitis B virus (HBV) persistence.
Programmed death-1 (PD-1) and its ligands, PD-L1/PD-L2,
are new members of CD28/B7 family, as co-stimulatory
molecules expressing on T cells and Antigen Present Cells
(APCs). Their engaging can downregulate the T cells
function, including proliferation, cytokines secretion and
cytotoxicity. In periphery blood, PD-1 was upreguated on
virus speciﬁc-T cells, leading to the impairment of T cells.
Blocking the PD-1/PD-L can improve the function of T cells.
Methods and Patients: 21 patients with chronic hepatitis B
(CHB) were treated by IFN-g (Pegintron, once a week,
0.5 or 1mg/kg/weight). The periphery blood were taken
at pretherpay, 4 weeks, 8 weeks, and 12 weeks.
Periphery blood mononuclear cells were isolated from fresh
heparinized blood by Ficoll-Hypaque (density:1.077 g/L)
density gradient centrifugation. The PD-1 expression on
lymphocytes was detected by ﬂow cytometry (FCM).
Results: The PD-1 expression on lymphocytes at pretherapy
was 14.47± 5.8%, at 4 weeks was 9.68± 3.75%, at 8 weeks
was 6.95± 2.39%, at 12 weeks was 6.08± 1.31% (p < 0.05).
Conclusion: Treatment of IFN-g can downregulate the PD-1
expression on lymphocytes. Say in other words, Treatment
of IFN-g can partially restore the function of T cells.
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Objective: To evaluate the antiviral efﬁcacy of
JianpiQinghua Prescription Combined with Lamivudine to
treat chronic hepatitis B differentiated as syndrome type
of liver depression and spleen asthenia accompanied by
